Goldman Sachs’s Amplify Treatments, Testing and Advancements ETF GERM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-10,372
| Closed | -$203K | – | 5017 |
|
|
2023
Q4 | $203K | Sell |
10,372
-27,168
| -72% | -$531K | ﹤0.01% | 4321 |
|
|
2023
Q3 | $672K | Sell |
37,540
-25,386
| -40% | -$454K | ﹤0.01% | 3745 |
|
|
2023
Q2 | $1.3M | Buy |
62,926
+32,376
| +106% | +$667K | ﹤0.01% | 3460 |
|
|
2023
Q1 | $625K | Sell |
30,550
-34,266
| -53% | -$701K | ﹤0.01% | 3963 |
|
|
2022
Q4 | $1.45M | Buy |
64,816
+26,682
| +70% | +$597K | ﹤0.01% | 3471 |
|
|
2022
Q3 | $791K | Buy |
38,134
+11,074
| +41% | +$230K | ﹤0.01% | 3974 |
|
|
2022
Q2 | $629K | Sell |
27,060
-45,638
| -63% | -$1.06M | ﹤0.01% | 4234 |
|
|
2022
Q1 | $1.99M | Buy |
72,698
+27,295
| +60% | +$747K | ﹤0.01% | 3593 |
|
|
2021
Q4 | $1.62M | Sell |
45,403
-798
| -2% | -$28.4K | ﹤0.01% | 3642 |
|
|
2021
Q3 | $1.9M | Buy |
46,201
+27,649
| +149% | +$1.13M | ﹤0.01% | 3536 |
|
|
2021
Q2 | $742K | Sell |
18,552
-10,709
| -37% | -$428K | ﹤0.01% | 4209 |
|
|
2021
Q1 | $1.04M | Hold |
29,261
| – | – | ﹤0.01% | 3875 |
|
|
2020
Q4 | $910K | Hold |
29,261
| – | – | ﹤0.01% | 3506 |
|
|
2020
Q3 | $809K | Buy |
+29,261
| New | +$809K | ﹤0.01% | 3427 |
|